Table 2.

Efficiency of Transduction Into Marmoset Hematopoietic Progenitor Cells

Transduction Method Cell StromaCytokine*Transduction Period
48 h 96 h 144 h
Supernatant  BMPC  −  +  ND 1.7 ± 0.6  ND  
  +  +  ND 5.6 ± 1.2  ND  
Cocultivation  BMPC  − −  1.0 ± 0.6  3.2 ± 1.0  5.9 ± 0.9 
  −  +  1.6 ± 0.2  5.5 ± 0.5 6.3 ± 1.2  
  +  −  11.6 ± 1.5 15.3 ± 1.9 16.5 ± 1.2 
  +  15.2 ± 1.5 23.2 ± 1.7, 20.9 ± 0.7, 
 PBPC  +  +  15.9 ± 4.0  14.8 ± 2.7 ND 
Transduction Method Cell StromaCytokine*Transduction Period
48 h 96 h 144 h
Supernatant  BMPC  −  +  ND 1.7 ± 0.6  ND  
  +  +  ND 5.6 ± 1.2  ND  
Cocultivation  BMPC  − −  1.0 ± 0.6  3.2 ± 1.0  5.9 ± 0.9 
  −  +  1.6 ± 0.2  5.5 ± 0.5 6.3 ± 1.2  
  +  −  11.6 ± 1.5 15.3 ± 1.9 16.5 ± 1.2 
  +  15.2 ± 1.5 23.2 ± 1.7, 20.9 ± 0.7, 
 PBPC  +  +  15.9 ± 4.0  14.8 ± 2.7 ND 

Transduction efficiency is represented as the percentage of VCR resistant colonies. Repetitive transduction in a coculture system of viral producer and marmoset bone marrow stromal cells facilitated efficient transduction efficiency. Data are expressed as the mean ± SEM from two separate experiments with the supernatant method and from three separate experiments with the cocultivation method.

Abbreviation: ND, not done.

*

Human SCF (100 ng/mL), IL-3 (20 ng/mL), IL-6 (80 ng/mL).

P < .01 when compared with the group without stromal cells, but with the same cytokine combination during the same transduction period.

P < .05 when compared with the group without cytokines, but with the same stromal cells condition during the same transduction period.

or Create an Account

Close Modal
Close Modal